Navitus Pharmacy Residency Posters

Developing the Next Generation of Pharmacy Leaders

Navitus Residency Program

Navitus’s 12-month, PGY1 Managed Care Residency Program helps residents become proficient in patient care and managed care pharmacy practice—all within a pharmacy benefit management (PBM) environment.

Learn more

Association of COVID-19 Vaccination Status With Nirmatrelvir/Ritonavir Utilization in Medicare Beneficiaries: A Retrospective Cohort Analysis
Predicting Stimulant and Opioid Co-Prescribing Among Members Initiating Opioid Therapy Using a Machine Learning Model
Association Between Utilization of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Events in Medicare Beneficiaries with Type 2 Diabetes
An Analysis of a Polypharmacy Deprescribing Program for Anticholinergics and Concurrent Opioid and Benzodiazepine Usage for Medicare Beneficiaries
Real-World Utilization of Targeted Immunomodulators for Chronic Conditions in a Commercially Insured Population
2025 Archive
Real-World Clinical Outcomes of an Adalimumab Biosimilar Transition Program
Improved Clinical Outcomes and Reduced Costs Associated With Mail-to-Prescriber Duplicate Therapy Deprescribing Interventions
Impact of a Mail-Based Intervention on Adherence to Direct Oral Anticoagulants Among Medicare and Medicaid Beneficiaries
Impact of Insulin Copay Cap Legislation on Savings, Adherence, and Utilization Among Health Plan Medicare Beneficiaries
An Automated Approach to Diagnosis Verification: Effects on Utilization of Glucagon-like Peptide-1 Agonists (GLP-1a)